Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous Metastases

Clinical trial NCT05481658 · RECRUITING

Trial details

NCT number: NCT05481658
Sponsor: Nicholas Gulati
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous Metastases

Start date: 2022-10-06
Primary completion: 2029-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.